title: Effects of sustained low-flow perfusion on the response to vasoconstrictor agents in postnatal intestine.
abstract: This laboratory has previously reported that sustained reduction of blood flow in newborn intestine causes a triphasic increase in vascular resistance that occurs over 3-4 h and that these changes are mediated, in part, by loss of endothelial nitric oxide (NO) production. This study examines the effects of exposure to sustained low-flow perfusion on the subsequent response to three contractile agonists: ANG II, norepinephrine (NE), and endothelin-1 (ET-1). Gut loops from 3- and 35-day-old swine were exposed to low-flow conditions in vivo (i.e., reduction of flow to approximately 50% of baseline) for 30 min or 5 h. Thereafter, they were removed to an extracorporeal perfusion circuit for in vitro hemodynamic assessment; alternatively, the mesenteric artery perfusing the gut loop was removed and cut into rings for assessment of isometric tension development. Gut loops from 3-day-old subjects exposed to low-flow conditions demonstrated significantly increased contractile responses to ANG II, NE, and ET-1; also, mesenteric artery rings from these gut loops demonstrated a significant reduction of the ED50 for all three agonists. Similar changes were not observed in intestine or mesenteric artery rings from older subjects. Sustained blockade of endogenous NO synthesis with NG-monomethyl- L-arginine duplicated the effects of exposure to sustained low-flow perfusion. It appears that sustained reduction of blood flow in newborn intestine decreases constitutive NO production, which in turn causes a generalized enhancement of the contractile efficacy of ANG II, NE, and ET-1.
authors.affiliation: Departments of Pediatrics and Physiology, The Ohio State University and The Wexner Institute for Pediatric Research, Children's Hospital, Columbus, Ohio 43205, USA. nowickip@pediatrics.ohio-state.edu
authors.forename: P T
authors.initials: PT
authors.lastname: Nowicki
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn / Q000235:genetics / Q000502:physiology*; D001775:Blood Circulation / Q000502:physiology*; D001808:Blood Vessels / Q000187:drug effects; D019332:Endothelin-1 / Q000494:pharmacology; D066298:In Vitro Techniques; D007422:Intestines / Q000098:blood supply*; D009638:Norepinephrine / Q000494:pharmacology; D013552:Swine; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
chemical_list: D019332:Endothelin-1; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D009638:Norepinephrine